T: 020 7842 1462 (DDI)
T: 020 7583 2222
E: claus.andersen@roydswithyking.com
Claus is a partner in our Corporate & Commercial and Life Sciences teams. He deals with all aspects of corporate and commercial work for corporate clients, limited companies, businesses, private individuals and trade organisations.
Claus was admitted to the High Courts of Denmark and the Copenhagen Maritime and Commercial Court in 2003. In addition, he was admitted as a solicitor in England and Wales in February 2008 and became a partner at Royds LLP in August 2011.
Claus has substantial experience in areas including company law, commercial contracts and finance, with particular emphasis on shareholders agreements, distribution agreements, general commercial contracts, the Bribery Act 2010 and the Exemption rules of the FSMA (Financial Promotion) order.
Claus is a member of the Danish Law Society.
Related articles
Recent weeks have in the news been dominated by Brexit, the withdrawal agreement, the suspension of Parliament and in the end the Queen’s speech.
Read more..
The Brexit task group at UK law firm Royds Withy King is advising business owners of the steps they need to take to make sure they can continue to trade with the EU in the event of a no deal Brexit.
Read more..
Your commercial contracts may be vulnerable to political changes. Have you considered if you need to renegotiate? Or engage with your supply chain? Or add extra protection for your IP?
Read more..
“The life sciences industry represents one of the dominant economic sectors in the UK.
It brings significant jobs and growth to virtually every region. To retain the UK’s competitive edge in this sector, there is a requirement for sustained effort over a longer period of time”.
Professor Sir John Bell, Regius Professor of Medicine, University of Oxford and Chairman, Office for the Strategic Coordination of Health Research.
The EU yesterday (20 November) announced that the European Medicines Agency will relocate from its Docklands home to Amsterdam when the UK leaves the EU in 2019, taking with it around 1,000 high value jobs. The move will, says Royds …
Read more..
The Serious Fraud Office (SFO) has this month announced a second deferred prosecution agreement which will see a firm pay more than £6million for corruption and bribery offences. The deal was reached between the unnamed company and SFO officials and …
Read more..
The Prime Minister has outlined new plans to curb corruption in business. David Cameron set out proposals for sweeping reforms to coincide with the start of an international summit and commentators claim that the measures will eclipse those previously included …
Read more..
A Partner from City-based solicitors Royds will be addressing a top international conference on the subject of the UK’s Bribery Act.
Read more..
“The life sciences industry represents one of the dominant economic sectors in the UK.
It brings significant jobs and growth to virtually every region. To retain the UK’s competitive edge in this sector, there is a requirement for sustained effort over a longer period of time”.
Professor Sir John Bell, Regius Professor of Medicine, University of Oxford and Chairman, Office for the Strategic Coordination of Health Research.
Long standing client from charity sector with a patient data base, came to us with the need for legal advice. It had been approached by a European Pharmaceutical, (EP). EP wanted to have access to our client’s database in order …
Read more..